ZYCLARA

This brand name is authorized in Austria, Canada, Estonia, Spain, France, Croatia, Ireland, Italy, Lithuania, Netherlands, Poland, United Kingdom, United States

Active ingredients

The drug ZYCLARA contains one active pharmaceutical ingredient (API):

1 Imiquimod UNII P1QW714R7M - IMIQUIMOD

Imiquimod is an immune response modifier. Saturable binding studies suggest a membrane receptor for imiquimod exists on responding immune cells. Imiquimod has no direct antiviral activity. Read about Imiquimod

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ZYCLARA Cream	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D06BB10	Imiquimod	D Dermatologicals → D06 Antibiotics and chemotherapeutics for dermatological use → D06B Chemotherapeutics for topical use → D06BB Antivirals
Discover more medicines within D06BB10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02340445
Country: EE	Ravimiamet	Identifier(s): 1592995, 1593008, 1593019
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 12783002
Country: FR	Base de données publique des médicaments	Identifier(s): 69349666
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 217359, 369189
Country: IT	Agenzia del Farmaco	Identifier(s): 043585013, 043585025, 043585037
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1067334, 1067335, 1067336
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 132020
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100288038
Country: US	FDA, National Drug Code	Identifier(s): 99207-270, 99207-271, 99207-276